NCT00505180

Completed

Accelerated Mortality on Renal Replacement

Massachusetts General Hospital Source

Compare

Other study identifiers

Sponsor study identifier

2003P000373

Secondary identifiers

5R21DK71674-2

5R21DK071674

NIH

Study Type

observational

Actual enrollment (reported)

10,018

Locations

0 countries

Sites

N/A

Timeline

Study Start

June 2004

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

Not reported

Date not reported

Study Completion

June 2006

Actual (reported)

Brief Summary

The purpose of this study is to prospectively identify blood markers that identify chronic hemodialysis patients at risk for early (\<90 days) and late (\>= 1 year) mortality

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 10,018 participants
Study completion date: June 2006
Actual (reported)
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
June 2004
Date type not reported
This date has not been verified as actual or estimated.
Study Completion
June 2006
Actual (reported)
First Submitted
July 19, 2007
Actual (reported)
First Posted
July 23, 2007
Actual (reported)

Last Updated: July 23, 2007
Status Verified: July 2007
Last Update Submitted: July 19, 2007

Conditions

End Stage Renal Disease

Keywords

HemodialysisMortality

Eligibility Criteria

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

End stage renal disease on hemodialysis at Fresenius Medical Center
New initiation of hemodialysis

You may not qualify if:

Death with 14 days of initiation of hemodialysis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Harvard University
Othercollaborator
Massachusetts Institute of Technology
Othercollaborator
Massachusetts General Hospital

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

Ravi I Thadhani, MD, MPH
Massachusetts General Hospital
PRINCIPAL INVESTIGATOR

Enrollment

10,018 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: DEFINED POPULATION
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER

Study Record Dates

First Submitted

July 19, 2007

First Posted

July 23, 2007

Study Start

June 2004

Date type not reported

This date has not been verified as actual or estimated.

Completed

NCT00160121

Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease

Phase 4Completed

NCT00151918

Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease

Phase 3Completed

NCT00113945

Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)

Phase 2Completed

NCT00110929

Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)

Phase 2Completed

NCT00374010

Improving Patient-clinician Communication About End-of-life Care

Phase 2Completed

NCT00586716

Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients

Not ApplicableTerminated

Otherlead

Cedars-Sinai Medical Center

Othercollaborator

Beth Israel Deaconess Medical Center

Othercollaborator

University of Pennsylvania

Othercollaborator

Study Completion

June 2006

Actual (reported)

Last Updated

July 23, 2007

Record last verified: 2007-07

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00505180
Data provider: ClinicalTrials.gov
Source updated: 2007-07-23
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:22:23 UTC

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Study Completion

First Submitted

First Posted

Conditions

Keywords

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record